Subscribe to Newsletter

Comprehensive

Subspecialties Basic & Translational Research

Disruption Ahead

| Jeff Pettey

A failure to meet preventable blindness targets speaks to the need for change

Business & Profession Professional Development

Change the Things You Can

| Lauren Hock

Everything you need to know about responding to patient-initiated verbal harassment

Subspecialties Comprehensive

Blood Ties

| Amy Shapiro

Hematology researchers are embarking on the world’s first collaborative natural history study on congenital plasminogen deficiency

Subspecialties Business and Innovation

Locked and (Pre)loaded

| Sponsored by FCI Ophthalmics

The world’s first injectable monocanalicular intubation stent

Subspecialties Business and Innovation

Business in Brief

| Phoebe Harkin

The latest industry news – in 60 words or less

Business & Profession Professional Development

Influential Black Ophthalmologists

| Aleksandra Jones

A series of firsts: we explore the Black figures who shaped the field

Subspecialties Comprehensive

Is #HopeInSight?

| Phoebe Harkin

Johnson & Johnson Vision release results of their global eye health survey in time for World Sight Day

Subspecialties Comprehensive

Residency 2.0

| Phoebe Harkin

The residents are back! Hear what they had to say in our latest roundtable.

Subspecialties Business and Innovation

Business in Brief

| Phoebe Harkin

The latest industry news – in 60 words or less

Subspecialties Basic & Translational Research

So Long, Lazy Eye

| Phoebe Harkin

Is subanesthetic ketamine the cure for amblyopia?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: